Literature DB >> 16579682

Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats.

Masaki Endo1, Shinji Kuroda, Hisatomo Kondo, Yutaka Maruoka, Keiichi Ohya, Shohei Kasugai.   

Abstract

Gene-activated matrix (GAM) is a matrix, such as collagen-containing plasmid vector, that encodes a protein to stimulate tissue regeneration. In the original GAM system, gene transfer efficiency was extremely low. We have recently reported that modifying GAM with calcium-phosphate precipitates (CaP) enhances the efficiency of gene transfer. The purpose of this study was to evaluate the effects of our modified GAM on tissue regeneration. We prepared critical size segmental bone defects in rat tibiae and transplanted GAM consisting of bovine atelocollagen and expression plasmid vector (bmp2), which encodes human BMP2, with or without CaP. The tibiae were later examined radiographically, histologically, and mechanically. Implantation of bmp2-CaP-collagen at 12 microg bmp2 bridged the bone defect at 4 weeks, and the strength of the bone was comparable to that of an intact tibia at 6 weeks. Implantation of bmp2-collagen at the same dose of bmp2 bridged the defect to a smaller extent. Neither collagen alone nor vacant vector-CaP-collagen bridged the defect. These results indicate that our modified GAM with CaP has the potential to be effective in tissue regeneration at lower plasmid DNA doses than used in previous studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16579682     DOI: 10.1089/ten.2006.12.489

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  24 in total

Review 1.  Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.

Authors:  Gadi Pelled; Ayelet Ben-Arav; Colleen Hock; David G Reynolds; Cemal Yazici; Yoram Zilberman; Zulma Gazit; Hani Awad; Dan Gazit; Edward M Schwarz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 2.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

3.  Cell-based gene therapy for repair of critical size defects in the rat fibula.

Authors:  Zawaunyka W Lazard; Michael H Heggeness; John A Hipp; Corinne Sonnet; Angie S Fuentes; Rita P Nistal; Alan R Davis; Ronke M Olabisi; Jennifer L West; Elizabeth A Olmsted-Davis
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

Review 4.  Engineering extracellular matrix through nanotechnology.

Authors:  Cassandra M Kelleher; Joseph P Vacanti
Journal:  J R Soc Interface       Date:  2010-09-22       Impact factor: 4.118

Review 5.  Gene therapy for bone healing.

Authors:  Christopher H Evans
Journal:  Expert Rev Mol Med       Date:  2010-06-23       Impact factor: 5.600

6.  An ectopic study of apatite-coated silk fibroin scaffolds seeded with AdBMP-2-modified canine bMSCs.

Authors:  Kaige Lü; Ling Xu; Lunguo Xia; Yilin Zhang; Xiuli Zhang; David L Kaplan; Xinquan Jiang; Fuqiang Zhang
Journal:  J Biomater Sci Polym Ed       Date:  2011-01-28       Impact factor: 3.517

7.  An efficient, non-viral dendritic vector for gene delivery in tissue engineering.

Authors:  D P Walsh; A Heise; F J O'Brien; S-A Cryan
Journal:  Gene Ther       Date:  2017-09-14       Impact factor: 5.250

8.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

9.  Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds.

Authors:  D M Salvay; M Zelivyanskaya; L D Shea
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

10.  Characterization and evaluation of the efficacy of cationic complex mediated plasmid DNA delivery in human embryonic palatal mesenchyme cells.

Authors:  Sheetal D'Mello; Aliasger K Salem; Liu Hong; Satheesh Elangovan
Journal:  J Tissue Eng Regen Med       Date:  2014-02-03       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.